{
  "slug": "false-positive-mammogram",
  "question": "What are the odds of getting a false-positive result on a mammogram?",
  "category": "health",
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Most women undergoing routine mammography screening expect the test to deliver a clean binary: cancer or no cancer. The possibility of a false alarm — being called back, re-imaged, possibly biopsied, only to learn the finding was benign — is not prominently communicated in screening brochures. No large-scale survey isolates \"fear of a false-positive mammogram\" as a standalone item, so the perceived side here is editorial intuition based on clinical-communication literature suggesting that most patients dramatically underestimate the cumulative callback rate.\n",
    "rough_estimate": "most patients guess well under 10% over a decade of screening",
    "kind": "intuition"
  },
  "native": {
    "display": "~9.6% false-positive recall per screening (subsequent mammograms)",
    "numerator": 96,
    "denominator": 1000,
    "unit": "per screening examination",
    "population": "US women undergoing screening mammography, BCSC registry"
  },
  "normalized": {
    "lifetime_us_adult": 0.491,
    "display": "~49% cumulative after 10 annual mammograms",
    "log_value": -0.31,
    "assumptions": "The Elmore et al. 1998 NEJM study estimated a 49.1% cumulative probability of at least one false-positive mammogram after 10 screening rounds (95% CI 40.3%–64.1%), based on 9,762 mammograms among 2,400 women aged 40–69. The later Hubbard et al. 2011 BCSC analysis of 386,799 mammograms found 61.3% (CI 59.4%–63.1%) for annual screening starting at age 40, and 41.6% for biennial screening. The normalized figure uses the Elmore point estimate as the central value because it is the more widely cited landmark; the uncertainty band spans the biennial-to-annual range from both studies.\n",
    "uncertainty": {
      "low": 0.403,
      "high": 0.613
    },
    "scope": "activity_specific_lifetime"
  },
  "sources": [
    {
      "url": "https://www.nejm.org/doi/full/10.1056/NEJM199804163381601",
      "title": "Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations",
      "publisher": "New England Journal of Medicine",
      "source_type": "peer_reviewed",
      "statistic": "49.1% cumulative false-positive probability after 10 mammograms (95% CI 40.3%–64.1%)",
      "excerpt": "\"The estimated cumulative risk of a false positive result was 49.1 percent (95 percent confidence interval, 40.3 to 64.1 percent) after 10 mammograms.\"\n",
      "source_date": "1998-04-16",
      "source_accessed": "2026-04-12",
      "archive_url": "http://web.archive.org/web/20260109225250/https://www.nejm.org/doi/full/10.1056/NEJM199804163381601",
      "calculation_notes": "Elmore et al. conducted a 10-year retrospective cohort of 2,400 women aged 40–69 with 9,762 screening mammograms. The per-examination false-positive rate was approximately 6.5% (mammogram alone); the cumulative 10-exam figure of 49.1% follows from the complement rule across independent screens. This is the native-to-normalized bridge: the \"lifetime\" here is 10 years of annual screening, not a biological lifetime.\n",
      "independence_note": "Elmore's cohort predates the BCSC registry and uses a single HMO population (Group Health Cooperative of Puget Sound). The BCSC analysis below draws from a separate, larger, multi-site dataset, providing an independent replication.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3209800/",
      "title": "Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography",
      "publisher": "Annals of Internal Medicine (via PMC)",
      "source_type": "peer_reviewed",
      "statistic": "61.3% cumulative false-positive recall after 10 annual screens starting at age 40 (95% CI 59.4%–63.1%); 41.6% for biennial screening",
      "excerpt": "\"The estimated cumulative probability of a false-positive recall after 10 years of annual screening starting at age 40 was 61.3% (95% CI, 59.4% to 63.1%). For biennial screening, the cumulative probability was 41.6% (CI, 40.6% to 42.5%).\"\n",
      "source_date": "2011-10-18",
      "source_accessed": "2026-04-12",
      "archive_url": "https://web.archive.org/web/20260413171759/https://pmc.ncbi.nlm.nih.gov/articles/PMC3209800/",
      "calculation_notes": "Hubbard et al. analyzed 386,799 mammograms from the NCI-funded Breast Cancer Surveillance Consortium (BCSC), interpreted by 997 radiologists. Per-screening false-positive recall was 16.3% at first screen, 9.6% at subsequent screens. Cumulative 10-year rates are computed via discrete-time survival analysis. The higher headline (61.3% vs. Elmore's 49.1%) likely reflects larger sample size, more recent practice patterns, and inclusion of digital mammography.\n",
      "independence_note": "BCSC is a multi-site NCI-funded registry covering seven US mammography registries. Hubbard's dataset is entirely independent of Elmore's single-HMO cohort.\n"
    },
    {
      "url": "https://www.cancer.gov/types/breast/hp/breast-screening-pdq",
      "title": "Breast Cancer Screening (PDQ) — Health Professional Version",
      "publisher": "National Cancer Institute",
      "source_type": "govt_report",
      "statistic": "Approximately 50% of women screened annually for 10 years experience a false-positive exam",
      "excerpt": "\"Approximately 50% of women screened annually for 10 years in the United States experience a false-positive exam; of these, 7% to 17% will undergo biopsies.\"\n",
      "source_date": "2025-03-14",
      "source_accessed": "2026-04-12",
      "archive_url": "https://web.archive.org/web/20260426200922/https://www.cancer.gov/types/breast/hp/breast-screening-pdq",
      "calculation_notes": "NCI's PDQ summary synthesizes the Elmore and BCSC findings into a round policy figure. Used here as the authoritative government source confirming the order of magnitude. The \"7% to 17% biopsy\" range corresponds to the BCSC false-positive biopsy recommendations.\n",
      "independence_note": "NCI PDQ is an independent editorial synthesis maintained by a board of cancer-screening experts. It cites both Elmore and Hubbard but applies its own editorial judgment on the summary statistic.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Death in a car crash (lifetime, US)",
      "lifetime_us_adult": 0.0108
    },
    {
      "label": "Winning a Powerball jackpot (per ticket)",
      "lifetime_us_adult": 3.4e-9
    },
    {
      "label": "Being audited by the IRS (per year, ~0.4%)",
      "lifetime_us_adult": 0.004
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Screening start age 40-49 vs 50-69",
      "multiplier": 1.5,
      "notes": "Hubbard et al. (Annals of Internal Medicine, 2011) BCSC analysis: cumulative 10-year false-positive recall rate for annual screening starting at age 40 was 61.3% vs approximately 42-50% for women starting at age 50; per-screen recall rate is higher in younger women partly due to denser tissue and absence of prior comparison images"
    },
    {
      "factor": "Dense breast tissue (ACR category C or D)",
      "multiplier": 2,
      "notes": "ACR and multiple BCSC-based analyses: dense breast tissue (heterogeneously or extremely dense, ~40-50% of screened women) approximately doubles the false-positive recall rate per examination, because dense tissue obscures findings and lowers radiologist specificity thresholds"
    },
    {
      "factor": "Annual vs biennial screening",
      "multiplier": 1.5,
      "notes": "Hubbard et al. (Annals of Internal Medicine, 2011): 10-year cumulative false-positive rate 61.3% for annual vs 41.6% for biennial screening — annual screening is approximately 1.5x more likely to produce at least one false positive over a decade"
    },
    {
      "factor": "Postmenopausal hormone therapy use",
      "multiplier": 1.4,
      "notes": "Multiple BCSC registry studies including Chlebowski et al. and Kerlikowske et al.: combined estrogen-progestin therapy increases breast density and mammographic recall rate; false-positive rates approximately 1.3-1.5x higher in current HRT users vs non-users"
    }
  ],
  "short_label": "False-positive mammogram",
  "outcome_severity": "minor_harm",
  "exposure_pattern": "recurring",
  "outcome_type": "inconvenience",
  "valence": "negative",
  "caveats": "This entry normalizes on a 10-year screening window, not a biological lifetime, because the clinically relevant question is \"how likely is a false alarm over a decade of routine mammography?\" not \"how likely over 59 years of being alive.\" The per-screening false-positive rate (~9.6% for subsequent exams) is roughly flat across age groups, but the cumulative figure depends entirely on screening frequency: biennial screening roughly halves the 10-year cumulative. Breast density, prior biopsies, hormone therapy use, and radiologist recall thresholds all modulate individual risk substantially. These are false-positive recalls and biopsies, not false-positive cancer diagnoses — downstream workup almost always resolves the finding, but not without cost, anxiety, and time.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 5,
    "d5": 5,
    "d6": 5,
    "d7": 3,
    "d8": 5,
    "avg": 4.75,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "claude-opus-4-6-research",
  "last_reviewed": "2026-04-16",
  "reviewed": true,
  "generated_at": "2026-04-12",
  "image": {
    "alt": "An abstract grid of small circles, most pale grey, a few highlighted in soft amber, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/false-positive-mammogram"
}